AIAkmaral Izbassarova

Akmaral Izbassarova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akmaral Izbassarova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Digital Cardiac Rehabilitation Following Coronary Revascularization: Effectiveness, Safety, Implementation Barriers and Future Development

    by Zulfiya Zhankalova, Balday Issenova, Zhansila Ismet, Gulnara Myrzabayeva, Rimma Suatbayeva, Akmaral Izbassarova, Anel Zhumabek, Balzhan Lakanova, Mukhtar Kulimbet, Almat Turysbekuly, et al.

    Background/Objectives: To critically review the effectiveness, safety and implementation of fully remote, hybrid and digitally supported cardiac rehabilitation (CR) in adults after coronary revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), distinguishing direct from indirect evidence. Methods: This structured narrative review drew on searches of MEDLINE (PubMed), Embase, the Cochrane Library, Scopus and Web of Science, supplemented by reference list and citation searching and by guidance from major cardiology societies. Randomized and non-randomized comparative studies, economic evaluations, qualitative studies and systematic reviews were selected purposively, appraised qualitatively for methodological limitations, and synthesized narratively by outcome, comparator, intervention comprehensiveness and directness of evidence for revascularized patients. Results: Compared with usual care, digital CR improved short-term exercise capacity; compared with center-based CR, it produced broadly similar exercise capacity and short- to intermediate-term quality of life. Lower odds of all-cause readmission with digital CR in one meta-analysis (OR 0.37, 95% CI 0.25–0.56) were based on only seven heterogeneous studies (n = 859) and are not corroborated by the 2023 Cochrane review; effects on major adverse cardiovascular events and mortality remain uncertain. Economic evaluations were generally favorable. Serious exercise-related adverse events were rarely reported in the selected, predominantly lower-risk participants studied, but surveillance was inconsistent, and safety after CABG and in higher-risk patients has not been established. Reimbursement, workforce capacity, interoperability and digital exclusion were the main implementation barriers. Conclusions: Comprehensive remote or hybrid CR is a reasonable option for appropriately assessed, clinically stable, lower-risk patients, particularly after PCI, and a promising way to reach those who would otherwise receive no rehabilitation; patients in the early period after CABG or at higher risk should start with supervised center-based or hybrid care. Digital CR should widen access to multidisciplinary rehabilitation rather than replace supervised programs, and adequately powered trials with long-term clinical and standardized safety outcomes are needed.

  • Open Access

    Perioperative Inflammatory Cytokine Profiles in Patients with Atrial Fibrillation Undergoing Catheter Treatment: A Prospective Observational Study from Kazakhstan

    by Kenzhebek Bizhanov, Adil Baimbetov, Alexander Sapunov, Akmaral Izbassarova, Akmoldir Sarsenbayeva

    Background/Objectives: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide, with inflammatory cytokines increasingly implicated in its development, persistence, and post-ablation recurrence. However, prospective perioperative cytokine data from Central Asia are lacking. The objective of the study is to evaluate temporal changes in inflammatory cytokines in AF patients undergoing catheter ablation and assess differences by AF type and recurrence status. Methods: In this prospective observational study conducted at the Syzganov National Scientific Center of Surgery, Almaty, Kazakhstan, 166 AF patients (mean age 66.1 ± 8.2 years; 57.8% male) were enrolled. Serum cytokines were measured using ELISA at baseline, immediately postablation, and at 6 months. Temporal changes were analysed using Friedman and Wilcoxon signed-rank tests, while between-group comparisons used Mann–Whitney U and Kruskal–Wallis tests. Results: IL-1β, IL-6, and IL-17A showed significant temporal changes (all p < 0.001). IL-6 increased immediately after ablation (0.088 to 0.122 pg/mL) before decreasing below baseline at 6 months (0.079 pg/mL). IL-17A progressively declined across all time points (0.073, 0.069, and 0.048 pg/mL). At 6 months, IL-1α levels were higher in primary versus recurrent AF (0.079 vs. 0.067 pg/mL; p = 0.047). Baseline IL-1β and IL-28A differed across AF subtypes (p = 0.040 and p = 0.014). No pre-operative cytokine independently predicted recurrence. Conclusions: AF ablation is associated with distinct cytokine trajectories, particularly for IL-1β, IL-6, and IL-17A. Cytokine profiles vary by AF type and recurrence, highlighting the potential role of immune monitoring in AF management. These findings should be regarded as exploratory and hypothesis-generating.